Search

Marian Pereira Guelakis

from Shelton, CT
Age ~49
Get Report
Also known as:
Marian P Guelakis, Marian S Guelakis, Marian P Pereira, Marian A Pereira, Maria Ana Pereira, Ana Maria Pereira, Marian Pereira I, Mariana Pereira
Phone and address:
21 Poe Pl, Huntington, CT 06484
(203) 513-2812
Connected to:
Scott A Guelcher, 55Savanna L Guelde, 36Cj C Gueldner, 67Donna H Gueldner, 66Richard Gueler, 58Anita Guelfi, 52Stephen H Guelig, 66Michelle J Guell, 45Miguel A Guelo, 60Emily Guelph, 62

Marian Guelakis Phones & Addresses

  • 21 Poe Pl, Shelton, CT 06484 (203) 513-2812
  • Cranford, NJ
  • Bernardsville, NJ
  • Somerset, NJ
  • Rochester, NY
  • Bridgeport, CT
  • Orange, CT

Work

Company: Celgene cellular therapeutics - Township of Warren, NJ 2005 Position: Project leader

Education

School / High School: University of Rochester School of Medicine and Dentistry- Rochester, NY Jan 1997 Specialities: Ph.D. in Biomedical Sciences

Skills

Cell Biology: mammalian tissue culture (... • transfection • stable cell line generation • cellular assays (i.e adhesion • viability • migration • signal transduction • luciferase reporter assays • stem cell differentiation) • tissue engineering ( i.e. engineering/ev... • magnetic assisted cell separation • immunofluorescence microscopy • confocal laser scanning microscopy • time-lapse microscopy Molecular Biology... • plasmid DNA isolation • recombinant protein purification • cloning • RNA purification • Northern and Southern blot analysis • cDNA array analysis • RT-PCR • PCR • radioactive labeling and handling • column chromatography • electrophoresis • Western immunoblot analysis • ELISA • immunoprecipitation • UV-VIS spectroscopy • dynamic light scattering

Resumes

Resumes

Marian Guelakis Photo 1

Research Scientist Ii

View page
Location:
21 Poe Pl, Shelton, CT 06484
Industry:
Biotechnology
Work:
Celgene
Research Scientist Ii
Education:
University of Rochester School of Medicine and Dentistry 1997 - 2003
Doctorates, Doctor of Philosophy, Molecular Biology Fairfield University 1993 - 1997
Marian Guelakis Photo 2

Shelton, Connecticut

View page
Location:
New York, NY
Industry:
Consumer Goods
Work:

Shelton, Connecticut
Skills:
Stem Cells
Tissue Engineering
Cell Signaling
Flow Cytometry
Cell Based Assays
Cell Biology
Cell Culture
Elisa
Western Blotting
Molecular Biology
Biomedical Engineering
Tissue Culture
Cell
Transfection
Immunohistochemistry
Biomaterials
Rt Pcr
In Vitro
Confocal Microscopy
Marian Guelakis Photo 3

Marian Guelakis Shelton, CT

View page
Work:
Celgene Cellular Therapeutics
Township of Warren, NJ
2005 to 2010
Project Leader
New Jersey Center for Biomaterials (NJCBM)
Piscataway, NJ
2003 to 2005
NIH Postdoctoral Fellow in Tissue Engineering and Biomaterials Science
Education:
University of Rochester School of Medicine and Dentistry
Rochester, NY
Jan 1997 to Jan 2003
Ph.D. in Biomedical Sciences
Skills:
Cell Biology: mammalian tissue culture (including primary and stem cells), transfection, stable cell line generation, cellular assays (i.e adhesion, viability, migration, signal transduction, luciferase reporter assays, stem cell differentiation), tissue engineering ( i.e. engineering/evaluating cell biomaterial interactions in 2D and 3D), magnetic assisted cell separation, immunofluorescence microscopy, confocal laser scanning microscopy, time-lapse microscopy Molecular Biology: bacterial culture, plasmid DNA isolation, recombinant protein purification, cloning, RNA purification, Northern and Southern blot analysis, cDNA array analysis, RT-PCR, PCR, radioactive labeling and handling, column chromatography, electrophoresis, Western immunoblot analysis, ELISA, immunoprecipitation, UV-VIS spectroscopy, dynamic light scattering

Publications

Us Patents

Methods And Compositions For Treatment Of Bone Defects With Placental Cell Populations

View page
US Patent:
20100047214, Feb 25, 2010
Filed:
Aug 24, 2009
Appl. No.:
12/546556
Inventors:
Sascha D. Abramson - Hillsborough NJ, US
Marian Guelakis - Cranford NJ, US
Mohammad A. Heidaran - Chatham NJ, US
Kristen Labazzo - Springfield NJ, US
Shmuel Yaccoby - Little Rock AR, US
International Classification:
A61K 35/50
C12N 5/071
US Classification:
424 937, 435325
Abstract:
Provided herein are osteogenic placental adherent cells (OPACs), methods of using OPACs and OPAC populations, and methods of culturing, proliferating, expanding, or differentiating the OPACs. Further provided herein are methods of using the OPACs to formulate implantable or injectable compositions suitable for administration to a subject. Still further provided herein are provides methods for treating bone defects with OPACs and compositions comprising OPACs. Also provided herein are methods of using OPACs in the treatment and management of multiple myeloma, e.g., reducing the progression of, halting the progression of, or improving, one or more symptoms of multiple myeloma in an individual having multiple myeloma, comprising administering a plurality of OPACs to the individual.

Methods And Compositions For Treatment Of Bone Defects With Placental Cell Populations

View page
US Patent:
20160151425, Jun 2, 2016
Filed:
Feb 2, 2016
Appl. No.:
15/013590
Inventors:
- Warren NJ, US
Marian Guelakis - Shelton CT, US
Mohammad A. Heidaran - Potomac MD, US
Kristen Labazzo - Springfield NJ, US
Shmuel Yaccoby - Little Rock AR, US
Assignee:
ANTHROGENESIS CORPORATION - Warren NJ
International Classification:
A61K 35/50
C12N 5/073
Abstract:
Provided herein are osteogenic placental adherent cells (OPACs), methods of using OPACs and OPAC populations, and methods of culturing, proliferating, expanding, or differentiating the OPACs. Further provided herein are methods of using the OPACs to formulate implantable or injectable compositions suitable for administration to a subject. Still further provided herein are provides methods for treating bone defects with OPACs and compositions comprising OPACs. Also provided herein are methods of using OPACs in the treatment and management of multiple myeloma, e.g., reducing the progression of, halting the progression of, or improving, one or more symptoms of multiple myeloma in an individual having multiple myeloma, comprising administering a plurality of OPACs to the individual.

Methods And Compositons For Treatment Of Bone Defects With Placental Cell Populations

View page
US Patent:
20140322177, Oct 30, 2014
Filed:
Mar 18, 2014
Appl. No.:
14/218465
Inventors:
- Warren NJ, US
Marian Guelakis - Shelton CT, US
Mohammad A. Heidaran - Chatham NJ, US
Kristen Labazzo - Springfield NJ, US
Shmuel Yaccoby - Little Rock AR, US
Assignee:
ANTHROGENESIS CORPORATION - Warren NJ
International Classification:
A61K 35/50
C12N 5/073
US Classification:
424 937, 435325
Abstract:
Provided herein are osteogenic placental adherent cells (OPACs), methods of using OPACs and OPAC populations, and methods of culturing, proliferating, expanding, or differentiating the OPACs. Further provided herein are methods of using the OPACs to formulate implantable or injectable compositions suitable for administration to a subject. Still further provided herein are provides methods for treating bone defects with OPACs and compositions comprising OPACs. Also provided herein are methods of using OPACs in the treatment and management of multiple myeloma, e.g., reducing the progression of, halting the progression of, or improving, one or more symptoms of multiple myeloma in an individual having multiple myeloma, comprising administering a plurality of OPACs to the individual.
Control profile
Marian Pereira Guelakis from Shelton, CT, age ~49 Get Report